mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |